Stress Urinary Incontinence resulting from a weak pelvic floor

INNOVO® is not yet available for sale in the US

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use

Stress Urinary Incontinence (SUI)

This is the term used when leaks accidentally occur from coughing, sneezing, laughing, jumping or doing heavy lifting. These simple movements put pressure on the bladder and, should the pelvic floor muscles be unable to tighten enough, will cause a leak. Stress incontinence is the most common type of urinary incontinence. It can happen at any age however is most common during pregnancy, after childbirth and during stages of menopause.

The prevalence of stress urinary incontinence in women

  • Stress urinary incontinence, the most prevalent form of incontinence among women, affects an estimated 15 million adult women in the U.S.1
  • One in four women over the age of 18 experience episodes of leaking urine involuntarily.1
  • On average, women wait 6.5 years from the first time they experience symptoms until they obtain a diagnosis for their bladder control problem(s).1

About us

INNOVO® is not yet available for sale in the US

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use

INNOVO® is a product of Atlantic Therapeutics, a developer of professional and consumer medical devices, related software, apps and connected health technologies. Atlantic Therapeutics focuses on the treatment of incontinence by strengthening muscles and modulating nerves of the pelvic floor.

We manufacture pelvic floor muscle strengthening and nerve stimulation products of medical device quality, supported by strong clinical evidence and subjected to controlled product trials.

Every product undergoes the same rigorous research and development process, so when you choose INNOVO® , you can be confident that it's been developed and manufactured to the highest standards and has proven to be safe and effective in clinical trials. Our team of scientists and R&D experts work closely with research hospitals, local and international universities to conduct sophisticated clinical trials. INNOVO® uses unique and patented technology.

The patented technology at the heart of INNOVO® has already been widely prescribed, helping thousands of European women overcome urinary incontinence.

Atlantic Therapeutics' offices are located in Galway, on the Atlantic coast of Ireland, London and Salem, close to Lake Constance in Germany.

All Atlantic Therapeutics Group Ltd. Product's are certified under EN ISO13485:2016


Our Clinical Advisory Board

  • Professor François Haab is a world leading urologist practicing in Urologie Paris Opéra and was previously Director of Urology at Hôpital Tenon (Assistance Publique)
  • Professor Ralf Tunn is Head of the Department of Urogynecology in Berlin and coordinator of the “Deutsches Beckenbodenzentrum” (German Pelvic Floor Centres)
  • Professor Linda Cardozo is an internationally recognised key opinion leader, Professor of Urogynaecology and Consultant Gynaecologist at King's College Hospital, London
  • Professor Roger R Dmochowski is Professor at the Department of Urology and Director of the Section of Female Pelvic Medicine at Vanderbilt University in Nashville
  • G. Willy Davila, MD, is Chairman of the Department of Gynecology and Head of Urogynecology and Reconstructive Pelvic Surgery at Cleveland Clinic Florida in Weston, Florida; Center Director for the Women's Health Institute in Weston and Clinical Director of Global Patient Services (GPS) for Cleveland Clinic Florida.
  • Associate Professor Ruth Maher is based at the Department of Physical Therapy, Creighton University in Omaha, and co-Inventor of INNOVO®
  • Sonja Soeder is Head of the German Pelvic floor centre in Berlin, the largest Physiotherapy centre in Germany
  • Non-Medical Advisor: David Kaysen is ex-CEO of Uroplasty, Diametrics Medical and Compex Technologies and is on the board of Cefaly. Dave has extensive experience in the clinical application and commercialization of neuromodulation therapies

For more information visit our corporate website

Source 1) National Association for Incontinence, Facts and Statistics